IL13RA2 and glioblastoma: Wu et al. designed polydopamine(PDA)-NPs, well-known for their photothermal conversion and biocompatibility,loaded with TMZ and modified with Pep-1 to target IL-13Ra2 overexpressedin both BBB and GBM cells.